ZNF141 mutations could be involved into a regulation of the different glycosylation status of CEACAM 5 and 6 that are targeted by NEO-201; however, further studies are needed to better understand the presence and relevance of this mutation in human cancers. This evidence concerns the gene ZNF141 and cancer.